NCT04721756View on ClinicalTrials.gov

Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
NeoplasmsNeoplasms Malignant
Interventions
DRUG

18F-LY3546117 Injection

370 megabecquerel (MBq) intravenous injection

PROCEDURE

PET Scan

positron emission tomography (PET) scan

Trial Locations (1)

Unknown

RECRUITING

Olivia Newton-John Cancer Institute and Austin Health, Heidelberg

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY